Science1 distinct publisher3 min readUpdated
Hiroshima University researchers report that swapping refined sucrose for sugarcane molasses changed the structure and activity of exopolysaccharides from Bacillus velezensis AZU-A3.
The Scientist · Science desk

Compiled by The ScientistSomething wrong?How this is made
A team at Hiroshima University fed the bacterium *Bacillus velezensis* AZU-A3 two different carbon sources, refined sucrose and sugarcane molasses, and got out two structurally different exopolysaccharides with measurably different biological activity [4][6][7]. For anyone costing a fermentation process, that reframes the feedstock line: the cheap agricultural byproduct is not a substitution to be tolerated but an input that changes the product [1][12].
Exopolysaccharides (EPSs) are the sugar polymers bacteria secrete into their surroundings, where they form protective layers and biofilms [2]. They are used in pharmaceuticals, medical coatings, surgical sealants and drug delivery systems, chosen for biocompatibility, biodegradability and low toxicity [10]. The persistent problem in that market is that the link between polysaccharide structure and biological function is poorly understood, which makes specifying a polymer harder than making one [11].
The Hiroshima group characterised the two products using vacuum-ultraviolet circular dichroism spectroscopy at the university's Research Institute for Synchrotron Radiation Science, alongside chromatographic tools [5]. Refined sucrose produced a polymer the authors call EPS-S, with an ordered, helical-like molecular conformation [6]. Molasses produced EPS-M, glucose-rich and with a more flexible conformation [7].
The flexible one performed better in the assays. EPS-M reached 94.23 percent free-radical scavenging activity against 76.43 percent for EPS-S, a gap of 17.8 percentage points [8][15]. It also showed significantly stronger antibacterial activity against *Escherichia coli*, *Salmonella enterica* and *Staphylococcus aureus* [9]. The researchers attribute the difference in performance to the greater structural flexibility of the molasses-derived polymer [7].
"A simple change in the carbon source dramatically altered the composition, structure and biological activity of the bacterial exopolysaccharides," said Mohamed Ibrahim, a specially appointed associate professor at the institute and lead author [3]. Ibrahim frames the practical use as two-sided: tailoring EPS properties for better antioxidant and antibacterial activity, and doing it with inexpensive substrates such as sugarcane molasses [12].
Two cautions before anyone reprices a process. First, the announcement reports no yields, titres, batch sizes or unit costs, and gives no numbers for the antibacterial results, only the direction [16]. Molasses is a variable, seasonally inconsistent input; a result showing that composition tracks the carbon source is also a result implying that lot-to-lot variation in the feed will show up in the polymer. Second, the mechanism is not established. The team says its next step is to investigate how different carbon sources regulate EPS biosynthesis, including the metabolic pathways and genes behind the changes in monosaccharide composition, conformation and activity [13]. Until that is mapped, this is a correlation between a feedstock and a product spec, useful but not yet controllable.
What to watch: whether the mechanistic follow-up identifies which pathway does the switching, since that is what would turn feedstock choice into a tunable process parameter rather than a two-option menu [13]. Also watch for evaluation in more advanced biological models, which Ibrahim says is planned, and for any data on whether EPS-M holds its structure and activity across molasses batches from different mills and seasons [13]. The work is published in the Chemical Engineering Journal by Khattab and colleagues [14].
Follow any of these and your For You feed starts watching them — no settings page required.
Ranked by verification strength, evidence, and original report placement.
Changing the carbon source used during bacterial fermentation can significantly influence the properties of the sugar polymers bacteria produce, known as bacterial exopolysaccharides (EPSs).
EPSs are secreted by bacteria into their surroundings, where they form protective layers or biofilms and serve as materials for medical and industrial applications.
"A simple change in the carbon source dramatically altered the composition, structure and biological activity of the bacterial exopolysaccharides," said Mohamed Ibrahim, a specially appointed associate professor at Hiroshima University's Research Institute for Synchrotron Radiation Science (HiSOR) and lead author of the study.
Sugarcane molasses produced a glucose-rich biopolymer (EPS-M) with a more flexible molecular conformation, and this greater structural flexibility allowed the molasses derivative to outperform the refined counterpart in biological tests.
EPS-M exhibited significantly stronger antibacterial activity than EPS-S against common pathogenic strains including Escherichia coli, Salmonella enterica and Staphylococcus aureus.
Bacterial EPSs are widely used in pharmaceuticals, medical coatings, surgical sealants and drug delivery systems because of their biocompatibility, biodegradability and low toxicity.
Evidence-backed comparisons of source perspectives and observed adoption signals. Read the methodology
Which Builder, Operator, and Investor concerns the observed source mix emphasized—not a truth score.
Evidence, demonstrated adoption, hype gap, incentives, and confidence are assessed independently, each on its own current evidence. How these are measured.
Peer-reviewed single-lab characterization, partly quantified
The core structural finding rests on a named peer-reviewed paper with a DOI and on instrumented characterization (VUVCD at HiSOR plus chromatography), and the antioxidant result is given as explicit percentages. Against that, the whole cluster is one press-announcement summary from a single publisher, the antibacterial advantage is reported only directionally, the flexibility-causes-activity link is asserted rather than demonstrated in the supplied text, and no process metrics or independent replication are present.
No adoption evidence in supplied sources
The only observable event in the cluster is a journal publication. There is no deployment, pilot, production run, licensing, pricing or third-party usage disclosure anywhere in the supplied source, and the researchers themselves place production optimization in future work, so adoption cannot be measured without inference.
Mildly overstated on economics and antibacterial strength
The structural and antioxidant findings are stated proportionately and are quantified. The overstatement is narrower but real: the headline promises biopolymers 'with stronger antibacterial effects' while the antibacterial result carries no numbers, and the piece extends a single bench comparison to a 'sustainable and economically viable approach' and cost-effective production without any yield, scale or unit-cost data. Modest positive gap rather than a large one, because the central lab claim is well supported.
Institutional research promotion
The single item is an announcement-style write-up built around a university's own study, quoting the lead author twice and naming the institution's synchrotron facility (HiSOR) as the analytical venue, with a forward-looking framing of future work and commercial relevance. That is a normal and disclosed research-communication incentive to present the result favourably, but no independent or adversarial assessment appears in the cluster to offset it. No commercial sponsor, vendor or funder incentive is disclosed in the supplied source, so this is scored on institutional promotion alone.
Moderate-low: one publisher, one primary study
Confidence in this assessment is limited by breadth rather than by the quality of the core finding: a single publisher, a single primary study, and no direct access to the paper's methods or data in the supplied material. The publication record and the quantified antioxidant comparison are firm; the causal, antibacterial and economic elements are single-sourced and unverified, and adoption is entirely unevidenced.
science
Penn State bioprints bone spheroids that carry a genetic switch for blood vessels1 distinct publisher
Distinct publishers with included, body-backed reporting in this cluster.
1 article · August 19, 2026